Utrogestan Indications/Uses

This medicine is prescribed for disorders related to a progesterone deficit: By oral route: Disorders related to Progesterone insufficiency and in particular: Pre-menstrual syndrome.
Menstrual irregularities due to ovulation disorders or anovulation.
Benign mastopathy.
Premenopause.
Adjunctive use with oestrogen in post-menopausal women; prevention of endometrial hyperplasia in non-hysterectomised postmenopausal women who are receiving estrogen therapy.
Infertility due to luteal phase defect.
Menace of abortion.
Menace of preterm delivery.
By vaginal route to help pregnancy, in particular: Progesterone support during ovarian insufficiency or complete ovarian failure in women lacking ovarian function (oocyte donation).
Luteal phase support during in vitro fertilization cycles.
Luteal phase support during spontaneous or induced cycles, in primary or secondary infertility or subfertility in particular due to dysovulation.
Threatened miscarriage or prevention of habitual miscarriage due to luteal phase deficiency up to the 12th week of pregnancy.
Preterm labour.
For all other Progesterone indications, the vaginal route represents an alternative to the oral route, in case of adverse events due to Progesterone (somnolence, dizziness).